Healthcare landscape has shifted towards the growing influence of payers and HTA bodies as gatekeepers of market access. Innovative technologies must demonstrate not only clinical efficacy, but also clear value for money. To remind resilient in this new environment, companies should redesign their operating models to create, demonstrate, and sustain value.
2503_Primemover_Rethinking Market Access Strategies for Innovative Medical Technologies